Mar 15, 2019 03:52 PM IST
Glenmark's current portfolio consists of 151 products authorised for distribution in the US.
- Mar 06, 2019 10:37 AM IST
"Alessandro is currently Executive Vice President, Oncology Therapeutics and Cell Therapy for Gilead Sciences. The appointment is effective April 2, 2019," Glenmark Pharma said in a regulatory filing.
- Mar 05, 2019 10:59 AM IST
The approved products is a generic version of Boehringer Ingelheim Pharmaceuticals Inc's Micardis HCT tablets.
- Feb 18, 2019 12:59 PM IST
The approval has been granted by the USFDA to Glenmark Pharmaceuticals, US, for clobetasol propionate foam, 0.05 percent, a generic version of Olux Foam, 0.05 percent, of Mylan Pharmaceuticals, the company said in a statement.
- Feb 11, 2019 12:32 PM IST
"Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (USFDA) for Sevelamer Hydrochloride tablets in the strengths of 400 mg and 800 mg," the company said in a BSE filing.
- Jan 10, 2019 02:12 PM IST
Ryaltris is indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age
- Jan 08, 2019 04:52 PM IST
Glenmark is targeting a consolidated revenue growth of 12-15 percent over the next 3-5 years, while focusing on margin expansion, the company said.
- Dec 18, 2018 11:08 AM IST
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the USFDA for Fluocinolone Acetonide Oil, 0.01 per cent (ear drops), a generic version of DermOtic Oil.
- Dec 17, 2018 11:38 AM IST
Glenmark said it is eligible for 180 days of competitive generic therapy (CGT) exclusivity upon commercialisation.
- Nov 26, 2018 10:58 AM IST
The approved product is a generic version of Mylan Pharmaceuticals Inc's Olux-E Foam, 0.05 per cent.
- Nov 22, 2018 11:06 AM IST
The approved drug is a generic version of GlaxoSmithKline's Mepron Oral Suspension of similar strength.
- Nov 22, 2018 10:04 AM IST
Atovaquone is a generic version of Mepron oral suspension, 750 mg/5 mL, of GlaxoSmithKline LLC.
- Nov 20, 2018 01:12 PM IST
The approval granted to Glenmark Pharmaceuticals Inc by by the US Food and Drug Administration (USFDA) is for Azelaic Acid Gel, 15 per cent, which is a generic version of Finacea Gel (15 per cent) of Leo Pharma, the company said in a statement.
- Nov 16, 2018 10:50 AM IST
Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Teriflunomide tablets in the strengths of 7 mg and 14 mg, the company said in a BSE filing.
- Nov 08, 2018 11:41 AM IST
"The company intends to file an Investigational New Drug (IND) application for GBR 1342 in solid tumors and initiate a clinical trial in 2019," the company said in a regulatory filing.
- Nov 01, 2018 11:22 AM IST
The product catering to both male and female patients will be exclusively marketed in Russia by Glenmark Impex LLC, a subsidiary of the company, under a licensing agreement with Denmark's Pharma Medico ApS.
- Oct 30, 2018 10:56 AM IST
The company's current portfolio consists of 141 products authorised for distribution at the US marketplace and 58 Abbreviated New Drug Applications (ANDAs) pending approval with the USFDA.
- Oct 26, 2018 01:27 PM IST
Glenmark Pharmaceuticals Inc has been granted final approval by the United States Food & Drug Administration (USFDA) for the oil in the strength of 0.01 percent, the Mumbai-based company said in a statement.
- Sep 17, 2018 11:30 AM IST
"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Estradiol Vaginal Inserts USP, 10 mcg," the company said in a regulatory filing Monday.
- Aug 11, 2018 10:35 AM IST
The new entity would be named as 'Integrace Private Ltd' and will market the product portfolio in India and Nepal, Glenmark said in a statement.
- Aug 11, 2018 10:00 AM IST
Total revenue from operations during the period under review was at Rs 2,165.62 crore. It was at Rs 2,363 crore in the same quarter last fiscal.
- Jul 17, 2018 03:05 PM IST
Glenmark disagrees with the findings of the Commission. While there is no material impact of the order, the company will file an appeal before the National Company Law Appellate Tribunal (NCLAT), the drug maker said.
- Jul 17, 2018 11:15 AM IST
Quoting IQVIA sales data for the 12-month period ended May 2018, the company said Welchol achieved annual sales of around $73 million.
- Jul 12, 2018 02:02 PM IST
The product has been developed by Helsinn, and Glenmark has exclusive marketing rights for it in India and Nepal, the company said in a statement.
- Jun 19, 2018 04:29 PM IST
The US Food and Drug Administration (USFDA) has provided its first supplemental Abbreviated New Drug Application (ANDA) approval for the company's plant in Monroe, Glenmark said in a statement.